How much CT does PET/CT need?;Wieviel CT braucht die PET/CT?

NuklearMedizin

Volumn 43, Issue 5, 2004, Pages 141-142

  Antoch, G ^a   Forsting, M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; EDITORIAL; HUMAN; METASTASIS; NUCLEAR MEDICINE; RADIOLOGY; THORAX; TREATMENT PLANNING;

EID: 7644230683     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625194     Document Type: Editorial

References (20)

1. 18F-FDG PET/CT. J Nucl Med 2004; 45: 56S-65S.
2. Beyer T, Antoch G, Muller S, et al. Acquisition protocol considerations for combined PET/CT imaging. J Nucl Med 2004; 45: 25S-35S.
3. Beyer T, Townsend DW, Brun T et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41: 1369-79.
4. Burgener FA, Hamlin DJ. Intravenous contrast enhancement in computed tomography of pelvic malignancies. rofo Fortschr Geb Röntgenstr Nuklearmed 1981; 134: 656-61.
5. Coppenrath E, Schmid C, Brandl R et al. Spiral CT of the abdomen: weight-adjusted dose reduction. Rofo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 2001; 173: 52-6.
6. Dean PB. Contrast media in body computed tomography: experimental and theoretical background, present limitations, and proposals for improved diagnostic efficacy. Invest Radiol 1980; 15: S164-9.
7. Goerres GW, von Schulthess GK, Steinert HC. Why most PET of lung and head-and-neck cancer will be PET/CT. J Nucl Med 2004; 45 (Suppl 1): 66S-71S.
8. 124I positron rays in metastatic follicular thyroid carcinoma. Nuklearmedizin 2002; 41: N68-71.
9. Gutzeit A, Debatin JF, Antoch G. Tumorstaging mit PET/CT: Detektion eines Zweittumors. Rofo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 2004; 176: 122-4.
10. Hany TF, Steinert HC, Goerres GW et al. PET diagnostic accuracy: improvement with in-line PET-CT system. Radiology 2002; 225: 575-81.
11. Hosten N, Kreissig R, Puls R et al. Fusion of CT and PET data: methods and clinical relevance for planning laser-induced thermotherapy of liver metastases. Rofo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 2000; 172: 630-5.
12. Lardinois D, Weder W, Hany TF et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348: 2500-7.
13. Prokop M. Radiation dose and image quality in computed tomography. Rofo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 2002; 174: 631-6.
14. Reske SN, Kotzerke J. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, »Onko-PET III«. Eur J Nucl Med 2001; 28: 1707-23.
15. Romer W, Avril N, Dose J et al. Metabolic characterization of ovarian tumors with positron-emission tomography and F-18 fluorodeoxyglucose. Rofo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 1997; 166: 62-8.
16. 8FDG-PET. Nuklearmedizin 2002; 41: 217-20.
17. Schoder H, Erdi YE, Larson SM et al. PET/CT: a new imaging technology in nuclear medicine. Eur J Nucl Med Mol Imaging 2003; 30: 1419-37.
18. Violante MR, Dean PB. Improved detectability of VX2 carcinoma in the rabbit liver with contrast enhancement in computed tomography. Radiology 1980; 134: 237-9.
19. Zatz LM. Iodinated contrast media in cranial tomography. Invest Radiol 1980; 15: S155-9.
20. Zimny M, Wildberger JE, Cremerius U et al. Combined image interpretation of computed tomography and hybrid PET in head and neck cancer. Nuklearmedizin 2002; 41: 14-21.